Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transition Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118027091A reveals efficient treprostinil route. Offers supply chain reliability and cost reduction in API manufacturing for global partners.
Novel C-H activation method for spiro quinazolinones offers high yield and scalability for reliable pharmaceutical intermediate supply chains.
Advanced carbonylative cross-coupling patent CN115385765B enables efficient alkyl aryl ketone production with reduced costs and enhanced supply chain reliability for global buyers.
Ruthenium-catalyzed preparation method offers high yield and industrial scalability for pharmaceutical intermediates supply chain optimization and significant cost reduction benefits.
Patent CN109912606B reveals a novel metal-free synthesis for pyrimidoindazoles. Discover cost-effective, scalable manufacturing for kinase inhibitor intermediates.
Discover a novel metal-free synthesis for pyrimidoindazole compounds via patent CN109912606B. Offers cost reduction in API manufacturing and scalable production.
Patent CN113307778A details a novel Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate supply.
Novel copper-catalyzed ring-opening allylation of cyclopropanols offers high-yield, green route for pharmaceutical intermediates and complex molecule synthesis.
Patent CN111892528A details a regioselective Ru-catalyzed C-H amidation method, offering cost-effective routes for high-purity pharmaceutical intermediates and scalable API manufacturing.
Novel one-step synthesis for spiro pyrrole-indolone derivatives. Enhances stereochemical control and scalability for reliable pharmaceutical intermediates supply chains.
Patent CN108314642B reveals a green triethylamine-based route for 2-methylpyridines. Offers cost reduction and scalable pharma intermediate manufacturing without heavy metals.
Patent CN109721590B details a novel cobalt-catalyzed method for C2 alpha acyloxy indole synthesis, offering cost reduction and improved regioselectivity for pharmaceutical intermediate manufacturing.
Novel iridium-catalyzed N-alkylation method for 2-(N-alkyl)aminopyrimidines using alcohols. High atom economy, water byproduct only. Ideal for pharma intermediates.
Patent CN115304557B reveals cost-effective manganese catalysis for enamine derivatives, offering supply chain stability and reduced manufacturing costs for pharmaceutical intermediates.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Novel metal-free synthesis of pyrimidoindazoles via one-pot cascade. High yields, mild conditions, ideal for API intermediates and kinase inhibitor development.
Novel Mo/Cu co-catalyzed method for 3-trifluoromethyl-1,2,4-triazoles offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN101717408B introduces a bis-phosphorus ylide ligand enabling high-yield alpha-arylation. This breakthrough offers significant cost reduction in API manufacturing and robust supply chain reliability.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.